144 related articles for article (PubMed ID: 36624463)
1. A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma.
Yu LL; Hu BW; Huang HX; Yu B; Xiao Q; Lv QL; Luo CH; Guo CX; Li JG; Xie XX; Yin JY
J Transl Med; 2023 Jan; 21(1):11. PubMed ID: 36624463
[TBL] [Abstract][Full Text] [Related]
2. A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma.
Wang Y; Xiao F; Zhao Y; Mao CX; Yu LL; Wang LY; Xiao Q; Liu R; Li X; McLeod HL; Hu BW; Huang YL; Lv QL; Xie XX; Huang WH; Zhang W; Guo CX; Li JG; Yin JY
Mol Cancer; 2022 Aug; 21(1):169. PubMed ID: 35999636
[TBL] [Abstract][Full Text] [Related]
3. Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients.
Guo Z; Wang YJ; He BS; Zhou J
Dis Markers; 2022; 2022():6707821. PubMed ID: 35990252
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma.
Benzeid R; Gihbid A; Tawfiq N; Benchakroun N; Bendahhou K; Benider A; Guensi A; El Benna N; Filali Maltouf A; Attaleb M; Chaoui I; Khyatti M; El Mzibri M
Asian Pac J Cancer Prev; 2023 Jan; 24(1):93-99. PubMed ID: 36708557
[TBL] [Abstract][Full Text] [Related]
5. An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma.
Cui Q; Feng QS; Mo HY; Sun J; Xia YF; Zhang H; Foo JN; Guo YM; Chen LZ; Li M; Liu WS; Xu M; Zhou G; He F; Yu X; Jia WH; Liu J; Zeng YX; Bei JX
Hum Mol Genet; 2016 Aug; 25(16):3626-3634. PubMed ID: 27436580
[TBL] [Abstract][Full Text] [Related]
6. How genome-wide SNP-SNP interactions relate to nasopharyngeal carcinoma susceptibility.
Su WH; Yao Shugart Y; Chang KP; Tsang NM; Tse KP; Chang YS
PLoS One; 2013; 8(12):e83034. PubMed ID: 24376627
[TBL] [Abstract][Full Text] [Related]
7. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
Wong AM; Kong KL; Chen L; Liu M; Wong AM; Zhu C; Tsang JW; Guan XY
Int J Cancer; 2013 Nov; 133(10):2284-95. PubMed ID: 23649311
[TBL] [Abstract][Full Text] [Related]
10. A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci.
Low JS; Chin YM; Mushiroda T; Kubo M; Govindasamy GK; Pua KC; Yap YY; Yap LF; Subramaniam SK; Ong CA; Tan TY; Khoo AS; ; Ng CC
PLoS One; 2016; 11(1):e0145774. PubMed ID: 26730743
[TBL] [Abstract][Full Text] [Related]
11. The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Guo C; Huang Y; Yu J; Liu L; Gong X; Huang M; Jiang C; Liao Y; Huang L; Yang G; Li J
Oncotarget; 2017 Apr; 8(15):25334-25344. PubMed ID: 28445979
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury.
Wang TM; Shen GP; Chen MY; Zhang JB; Sun Y; He J; Xue WQ; Li XZ; Huang SY; Zheng XH; Zhang SD; Hu YZ; Qin HD; Bei JX; Ma J; Mu J; Yao Shugart Y; Jia WH
J Natl Cancer Inst; 2019 Jun; 111(6):620-628. PubMed ID: 30299488
[TBL] [Abstract][Full Text] [Related]
13. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional variants of autophagy-related genes are associated with the efficacy and toxicity of radiotherapy in patients with nasopharyngeal carcinoma.
Yang Z; Liu Z
Mol Genet Genomic Med; 2019 Dec; 7(12):e1030. PubMed ID: 31692259
[TBL] [Abstract][Full Text] [Related]
15. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.
Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH
Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of ERCC1 mRNA Level from Receiver-Operator Characteristic and Pretreatment EBV-DNA Virus Load in Stage II Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy with Concurrent Cisplatin.
Hua L; Chen S; Wei M; Shen Y; Long J; Lin Z; Meng Y; Guo C; Huang H; Tu X; Yao M
Cancer Biother Radiopharm; 2022 Feb; 37(1):2-10. PubMed ID: 33764811
[No Abstract] [Full Text] [Related]
18. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
